Skip to main content

Moira Ann Rynn, MD

Chair of Psychiatry and Behavioral Sciences
Co-Division Director, Behavioral Medicine & Neurosciences (interim)
Consulting Professor in the Department of Psychiatry and Behavioral Sciences
Division: 
Child & Family Mental Health & Developmental Neuroscience

Dr. Rynn is Chair for the Department of Psychiatry and Behavioral Sciences at Duke University School of Medicine. She is an internationally-renowned expert in the treatment of pediatric mood and anxiety disorders. She has spent her career focused on improving treatments for children, adolescents, and young adults with treatment refractory mood and anxiety disorders. Her most recent studies have examined novel augmentation treatment strategies for pediatric Obsessive-Compulsive Disorder and treatment models for adolescent depression in the primary care setting.  Dr. Rynn received her medical degree from Rutgers University. She completed her internship and residency in psychiatry at the University of Pennsylvania Perelman School of Medicine and served as Chief Resident.  After completing her adult psychiatry training, she completed a Child and Adolescent Psychiatry Fellowship at the Children’s Hospital of Philadelphia followed by a Neuropsychopharmacology Research Fellowship sponsored by the NIMH at the University of Pennsylvania Perelman School of Medicine. Prior to joining Columbia University, Dr. Rynn was medical director of the Mood and Anxiety Disorders Section of the Department of Psychiatry at the University of Pennsylvania Perelman School of Medicine.

Education and Training

  • Postdoctoral Research Fellow, Psychiatry, National Institutes of Health, 1997 - 1998
  • Resident, Division of Child and Adolescent Psychiatry, Psychiatry, Children's Hospital of Philadelphia, 1995 - 1997
  • Chief Resident, Psychiatry, Psychiatry, University of Pennsylvania, School of Medicine, 1994 - 1995
  • Resident, Adult Psychiatry, Psychiatry, University of Pennsylvania, School of Medicine, 1992 - 1995
  • Intern in Psychiatry, Psychiatry, University of Pennsylvania, School of Medicine, 1991 - 1992
  • M.D., Rutgers, New Jersey Medical School, 1991

Publications

Cyr, Marilyn, David Pagliaccio, Paula Yanes-Lukin, Martine Fontaine, Moira A. Rynn, and Rachel Marsh. “Altered network connectivity predicts response to cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.” Neuropsychopharmacology 45, no. 7 (June 2020): 1232–40. https://doi.org/10.1038/s41386-020-0613-3.

Full Text

Cyr, Marilyn, David Pagliaccio, Paula Yanes-Lukin, Martine Fontaine, Moira A. Rynn, and Rachel Marsh. “Correction: Altered network connectivity predicts response to cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.” Neuropsychopharmacology 45, no. 7 (June 2020): 1241. https://doi.org/10.1038/s41386-020-0647-6.

Full Text

Pagliaccio, David, Jiook Cha, Xiaofu He, Marilyn Cyr, Paula Yanes-Lukin, Pablo Goldberg, Martine Fontaine, Moira A. Rynn, and Rachel Marsh. “Structural neural markers of response to cognitive behavioral therapy in pediatric obsessive-compulsive disorder.” J Child Psychol Psychiatry, December 31, 2019. https://doi.org/10.1111/jcpp.13191.

Full Text

Sanchez, Amanda L., Jonathan S. Comer, Stefany Coxe, Anne Marie Albano, John Piacentini, Scott N. Compton, Golda S. Ginsburg, et al. “The Effects of Youth Anxiety Treatment on School Impairment: Differential Outcomes Across CBT, Sertraline, and their Combination.” Child Psychiatry Hum Dev 50, no. 6 (December 2019): 940–49. https://doi.org/10.1007/s10578-019-00896-3.

Full Text

Mufson, Laura, and Moira A. Rynn. “Primary Care: Meeting the Mental Health Care Needs of Adolescents With Depression.” J Am Acad Child Adolesc Psychiatry 58, no. 4 (April 2019): 389–91. https://doi.org/10.1016/j.jaac.2018.10.014.

Full Text

Strawn, J. R., E. T. Dobson, A. B. Ramesh, S. A. Berger, and M. A. Rynn. “Pharmacologic treatment of pediatric anxiety disorders.” In Pediatric Anxiety Disorders, 359–84, 2019. https://doi.org/10.1016/B978-0-12-813004-9.00017-7.

Full Text

Albano, Anne Marie, Jonathan S. Comer, Scott N. Compton, John Piacentini, Philip C. Kendall, Boris Birmaher, John T. Walkup, et al. “Secondary Outcomes From the Child/Adolescent Anxiety Multimodal Study: Implications for Clinical Practice.” Evid Based Pract Child Adolesc Ment Health 3, no. 1 (2018): 30–41. https://doi.org/10.1080/23794925.2017.1399485.

Full Text

Kiff, Cara J., Stephanie Ernestus, Araceli Gonzalez, Philip C. Kendall, Anne Marie Albano, Scott N. Compton, Boris Birmaher, et al. “The Interplay of Familial and Individual Risk in Predicting Clinical Improvements in Pediatric Anxiety Disorders.” J Clin Child Adolesc Psychol 47, no. sup1 (2018): S542–54. https://doi.org/10.1080/15374416.2018.1460848.

Full Text

Strawn, Jeffrey R., Eric T. Dobson, Jeffrey A. Mills, Gary J. Cornwall, Dara Sakolsky, Boris Birmaher, Scott N. Compton, et al. “Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.” J Child Adolesc Psychopharmacol 27, no. 6 (August 2017): 501–8. https://doi.org/10.1089/cap.2016.0198.

Full Text

Strawn, Jeffrey R., Scott N. Compton, Brigitte Robertson, Anne Marie Albano, Mohamed Hamdani, and Moira A. Rynn. “Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.” J Child Adolesc Psychopharmacol 27, no. 1 (February 2017): 29–37. https://doi.org/10.1089/cap.2016.0132.

Full Text

Pages